Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 19.28%1.24B | 20.31%895.11M | 44.00%240.03M | 27.61%1.32B | 25.98%1.04B | 28.47%744.03M | 10.02%166.68M | 20.66%1.03B | 20.90%823.53M | 31.93%579.15M |
| Operating revenue | 19.28%1.24B | 20.31%895.11M | 44.00%240.03M | 27.61%1.32B | 25.98%1.04B | 28.47%744.03M | 10.02%166.68M | 20.66%1.03B | 20.90%823.53M | 31.93%579.15M |
| Other operating revenue | ---- | 23.43%496.57K | ---- | 17.66%773.95K | ---- | 7.35%402.3K | ---- | 49.30%657.8K | ---- | 121.93%374.76K |
| Total operating cost | 26.98%942.11M | 27.21%683.83M | 49.78%195.09M | 27.15%982.41M | 21.23%741.94M | 22.33%537.56M | 0.86%130.26M | 14.78%772.61M | 16.53%611.99M | 26.53%439.43M |
| Operating cost | 19.45%516.37M | 22.13%375.85M | 37.58%101.6M | 22.28%551.38M | 19.61%432.28M | 19.55%307.76M | 3.36%73.85M | 14.99%450.93M | 15.47%361.4M | 26.23%257.44M |
| Operating tax surcharges | 7.46%12.29M | -2.13%8.35M | 22.29%3.05M | 55.87%14.83M | 48.19%11.43M | 63.70%8.53M | 59.00%2.49M | 7.21%9.52M | 14.24%7.72M | 49.95%5.21M |
| Operating expense | 30.92%370.38M | 26.66%270.77M | 50.23%75.49M | 41.25%379.59M | 35.57%282.9M | 38.23%213.79M | 14.68%50.25M | 15.88%268.74M | 18.22%208.67M | 28.80%154.66M |
| Administration expense | 14.06%24.47M | 15.50%16.24M | 23.01%8.85M | -2.04%32.27M | 5.73%21.45M | 1.30%14.06M | 2.82%7.19M | 30.24%32.95M | 9.70%20.29M | 6.88%13.88M |
| Financial expense | 78.74%-6.53M | 82.26%-3.78M | 84.79%-1.58M | -102.08%-30.74M | -607.98%-30.74M | -462.85%-21.33M | -3,262.73%-10.41M | -230.23%-15.21M | -17.42%-4.34M | -65.26%-3.79M |
| -Interest expense (Financial expense) | -37.38%65.77K | -31.95%47.04K | -34.14%25.11K | -48.67%131.57K | -48.27%105.03K | -57.00%69.12K | -59.71%38.12K | -40.20%256.3K | -34.41%203.02K | -29.58%160.77K |
| -Interest Income (Financial expense) | 78.36%-6.69M | 81.89%-3.89M | 84.47%-1.63M | -99.05%-30.98M | -568.33%-30.92M | -435.50%-21.46M | -2,341.86%-10.46M | -203.16%-15.56M | -13.19%-4.63M | -56.90%-4.01M |
| Research and development | 2.12%25.14M | 11.08%16.4M | 11.75%7.69M | 36.49%35.07M | 34.83%24.61M | 22.69%14.76M | 22.26%6.88M | 31.68%25.69M | 29.13%18.26M | 32.17%12.03M |
| Credit Impairment Loss | -62.77%-986.45K | -85.97%-3.43M | -2.70%-437.08K | -229.17%-488.66K | -54.48%-606.02K | -747.78%-1.85M | -146.04%-425.58K | -320.14%-148.45K | 38.90%-392.31K | 31.83%-217.68K |
| Asset Impairment Loss | 31.22%-1.62M | 44.51%-2.31M | 32.97%-1.68M | 24.50%-1.82M | -1,003.94%-2.36M | -930.84%-4.15M | -746.06%-2.51M | -113.42%-2.41M | 63.55%-213.94K | 32.43%-403.07K |
| Adjustment items of total operating cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- |
| Other net revenue | 511.19%18.32M | 692.81%8.99M | 494.89%5.54M | 165.18%11.33M | -38.40%3M | -195.46%-1.52M | -4,205.82%-1.4M | 49.78%4.27M | 235.04%4.87M | 75.19%1.59M |
| Fair value change income | --404.47K | --791.91K | --4.77M | --3.59M | ---- | ---- | ---- | ---- | ---- | ---- |
| Invest income | 1,366.06%15.14M | 2,109.80%10.45M | 919.25%1.54M | 360.11%3.86M | 106.74%1.03M | 345.17%472.72K | 731.16%151.35K | -59.05%838.63K | -58.10%499.65K | -86.09%106.19K |
| Asset deal income | 133.83%80.15K | 133.83%80.15K | 99.31%-1.44K | -704.17%-507.89K | -382.42%-236.92K | -381.83%-236.92K | ---210.51K | 77.67%84.06K | --83.89K | --84.06K |
| Other revenue | 2.62%5.3M | -19.64%3.41M | -15.19%1.35M | 13.34%6.7M | 5.73%5.17M | 110.29%4.25M | 279.59%1.59M | 207.32%5.91M | 228.34%4.89M | 90.66%2.02M |
| Operating profit | 5.08%313.74M | 7.48%220.27M | 44.11%50.47M | 31.17%347.1M | 37.97%298.57M | 45.03%204.94M | 56.91%35.02M | 42.42%264.62M | 37.46%216.4M | 52.60%141.31M |
| Add:Non operating Income | -99.54%23.37K | -99.66%17.1K | -99.30%35.01K | 54.78%5.14M | 1,634.56%5.08M | 9,551.06%5.04M | 41,541.59%5.03M | 34.20%3.32M | -87.79%292.73K | -97.73%52.19K |
| Less:Non operating expense | 75.78%197.11K | 1,335.13%141.27K | 1,223.70%109K | 2,057.60%231.52K | 2,106.28%112.13K | 5,495.12%9.84K | 7,740.97%8.23K | 1,687.20%10.73K | 1,879.70%5.08K | 430.07%175.93 |
| Total profit | 3.30%313.56M | 4.85%220.15M | 25.87%50.4M | 31.38%352M | 40.08%303.54M | 48.54%209.97M | 79.30%40.04M | 42.31%267.93M | 35.58%216.69M | 48.96%141.36M |
| Less:Income tax cost | 11.41%47.52M | 8.94%32.62M | 35.73%6.2M | 23.73%51.84M | 18.62%42.65M | 36.79%29.94M | 277.89%4.57M | 48.43%41.9M | 26.83%35.96M | 33.87%21.89M |
| Net profit | 1.98%266.05M | 4.16%187.52M | 24.60%44.2M | 32.80%300.16M | 44.35%260.88M | 50.69%180.03M | 67.93%35.47M | 41.23%226.03M | 37.47%180.73M | 52.10%119.47M |
| Net profit from continuing operation | 1.98%266.05M | 4.16%187.52M | 24.60%44.2M | 32.80%300.16M | 44.35%260.88M | 50.69%180.03M | 67.93%35.47M | 41.23%226.03M | 37.47%180.73M | --119.47M |
| Net profit of parent company owners | 1.98%266.05M | 4.16%187.52M | 24.60%44.2M | 32.80%300.16M | 44.35%260.88M | 50.69%180.03M | 67.93%35.47M | 41.23%226.03M | 37.47%180.73M | 52.10%119.47M |
| Earning per share | ||||||||||
| Basic earning per share | 3.13%0.66 | 4.55%0.46 | 22.22%0.11 | 15.63%0.74 | 20.75%0.64 | 25.71%0.44 | 50.00%0.09 | 36.17%0.64 | 39.47%0.53 | 52.17%0.35 |
| Diluted earning per share | 3.13%0.66 | 4.55%0.46 | 22.22%0.11 | 15.63%0.74 | 20.75%0.64 | 25.71%0.44 | 50.00%0.09 | 36.17%0.64 | 39.47%0.53 | 52.17%0.35 |
| Other composite income | ||||||||||
| Total composite income | 1.98%266.05M | 4.16%187.52M | 24.60%44.2M | 32.80%300.16M | 44.35%260.88M | 50.69%180.03M | 67.93%35.47M | 41.23%226.03M | 37.47%180.73M | 52.10%119.47M |
| Total composite income of parent company owners | 1.98%266.05M | 4.16%187.52M | 24.60%44.2M | 32.80%300.16M | 44.35%260.88M | 50.69%180.03M | 67.93%35.47M | 41.23%226.03M | 37.47%180.73M | 52.10%119.47M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Guangdong Sinong Accounting Firm (Special General Partnership) | -- | -- | -- | Guangdong Sinong Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.